Pfizer Staph Vaccine Trial May Support Claim For Some, But Not All, Orthopedic Surgeries

US FDA advisory committee members say if SA4Ag is efficacious in ongoing trial of spinal surgery patients, efficacy data could support a broader claim encompassing limited number of other orthopedic procedures with similar pathophysiology and infection risk, such as hip and knee replacement surgeries.